SCAI

This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies. 
 

News | Structural Heart Occluders

March 27. 2019 — A newly released expert consensus statement provides recommendations for the safe and effective ...

Home March 27, 2019
Home
The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22, with feature a peripheral vascular track with interactive sessions. Henry Ford Hospital CTO case.
Feature | SCAI | Subhash Banerjee, M.D., FSCAI, Abu-Fadel Mazen, M.D., FSCAI and Rajesh Swaminathan, M.D., FSCAI

The Society for Cardiovascular Angiography and Interventions (SCAI) 2019 Scientific Sessions in Las Vegas, May 19-22 ...

Home February 25, 2019
Home
The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...

Home January 25, 2019
Home
News | FFR Technologies

July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert consensus ...

Home July 26, 2018
Home
A CoreValve TAVR valve seen in a CT scan looking down from the aortic arch into the left ventricle using reconstruction software from TeraRecon.
Feature | Heart Valve Technology

July 26, 2018 — A new multi-societal expert consensus document has been released that summarizes the position of these ...

Home July 26, 2018
Home
Two versions of the Abiomed Impella percutaneous ventricular assist device being shown at ACC 2018. Impella is the only device currently cleared by the FDA for use in cardiogenic shock.
Feature | Hemodynamic Support Devices | Emmanouil S. Brilakis, M.D., Ph.D., FSCAI and Srihari S. Naidu, M.D., FSCAI
Cardiogenic shock (CS) is a low-cardiac-output state resulting in life-threatening end-organ hypoperfusion and hypoxia ...
Home July 08, 2018
Home
News | Atrial Fibrillation

May 15, 2018 – Results of the AVIATOR 2 international registry data show a discrepancy between physician perception and ...

Home May 15, 2018
Home
News | Peripheral Artery Disease (PAD)

May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to ...

Home May 15, 2018
Home
News | Cath Lab

May 15, 2018 — Revised guidelines incorporating new data on discharge criteria for patients undergoing elective percutan ...

Home May 15, 2018
Home
No Benefit Found Using Sodium Bicarbonate, Acetylcysteine to Prevent Kidney Injury, the result of the PRESERVE Trial to prevent acute kidney injury (AKI), presented at SCAI 2018.  #SCAI, #SCAI2018,
Feature | Cath Lab

May 15, 2018 – The large-scale, international randomized PRESERVE clinical trial found high-risk patients for renal ...

Home May 15, 2018
Home
News | Cath Lab

May 15, 2018 — A contemporary, real-world analysis shows lower mortality rates when culprit-only intervention is used ...

Home May 15, 2018
Home
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018
Feature | Cardiovascular Clinical Studies

May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin ...

Home May 14, 2018
Home
A 3-D printed aortic root with an simulated implant of an Edwards Sapien TAVR valve. New clinical data points to length-of-stay as a new predictor of outcomes in TAVR patients. Image from Henry Ford Hospital.
Feature | Heart Valve Technology

May 14, 2018 – A new study finds patients who stay in the hospital for more than 72 hours when undergoing trans-femoral ...

Home May 14, 2018
Home
News | Chronic Total Occlusion (CTO)

May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention ...

Home May 14, 2018
Home
News | Peripheral Artery Disease (PAD)

May 14, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD ...

Home May 14, 2018
Home
Subscribe Now